Benign Bone Neoplasm C&P Exam Prep

Range of Motion Testing (Active and Passive)

What it measures: The degrees of motion available in the joint or region adjacent to or affected by the benign bone neoplasm, measured with a goniometer. Used to identify motion-limiting impairment caused by the neoplasm, post-surgical residuals, or pain inhibition.

What to expect: The examiner will ask you to move the affected joint/limb as far as you can on your own (active ROM), then may gently move it themselves (passive ROM). They will note where motion stops and whether pain limits further movement before the anatomical end range. Testing should be performed both weight-bearing and non-weight-bearing for lower extremity conditions.

Pain considerations: Under DeLuca v. Brown, the examiner must document pain on motion, weakness, fatigue, and incoordination - all of which may reduce your effective ROM below what is measured on a single test. If your pain, fatigue, or weakness causes functional loss beyond what the goniometer records, explicitly tell the examiner: 'My pain/fatigue causes me to lose additional function that this measurement does not show.'

Physical Palpation and Inspection of Neoplasm Site

What it measures: Location, size, tenderness, firmness, and any visible deformity or swelling of the benign bone neoplasm. Also evaluates overlying skin for scars, disfigurement, or surgical changes.

What to expect: The examiner will visually inspect and press on the area where the neoplasm is located. They will assess for tenderness to palpation, warmth, swelling, and bony deformity. If surgery has been performed, they will inspect the scar.

Pain considerations: Pain on palpation is a key finding that supports symptomatic benign neoplasm. Accurately communicate both the intensity (e.g., 7/10 sharp pain) and the nature (aching, throbbing, stabbing) of pain when the examiner touches the area.

Functional Impairment Assessment

What it measures: How the benign bone neoplasm and any residuals (post-surgical, from complications, or from the neoplasm itself) affect the veteran's ability to perform occupational and daily activities.

What to expect: The examiner will ask you questions about your ability to walk, lift, carry, stand, sit, and perform daily activities. They will assess whether you use assistive devices and how frequently. For extremity involvement, they will identify which extremity is affected (right/left, upper/lower) and document functional loss.

Pain considerations: Functional loss due to pain, even when structural ROM appears acceptable, is fully ratable under DeLuca. Explicitly state: 'The pain from my bone neoplasm causes me to [specific activity limitation] even when my range of motion appears normal on testing.'

Imaging and Diagnostic Test Review

What it measures: Radiographic and pathological confirmation of the benign bone neoplasm type, location, size, and any associated bone changes (cortical thinning, expansion, fracture risk). Includes X-ray, MRI, CT, bone scan, and bone biopsy/culture results.

What to expect: The examiner will review available imaging in the claims file and may order new imaging if needed. They will document dates of tests and results. Biopsy results confirming benign pathology (e.g., osteochondroma, enchondroma, giant cell tumor, fibrous dysplasia) are particularly important.

Pain considerations: Imaging findings alone do not capture your subjective pain and functional loss. Ensure the examiner understands that imaging may underrepresent your actual impairment - particularly on days when pain, swelling, or flare-ups are at their worst.

0%

Benign bone neoplasm with no current symptoms, no functional impairment, no treatment required, and no demonstrable effect on the use of the affected part. The condition may be present but is entirely asymptomatic and non-limiting.

From 38 CFR: Under DC 5015, benign neoplasms of bone are rated on the basis of the symptomatology and functional impairment they cause, analogous to the rating criteria for the affected bone or joint. A non-symptomatic, non-limiting benign neoplasm would receive a non-compensable (0%) rating.

10%

Benign bone neoplasm causing mild but definite symptoms - intermittent pain with activity, mild limitation of function in the affected area, or minor post-treatment residuals. Condition is symptomatic but does not substantially restrict daily activities or require regular assistive device use.

From 38 CFR: DC 5015 rates benign neoplasms analogously to the impairment caused. A 10% rating is typical when symptoms are real but mild - for example, mild painful limitation of a joint analogous to a 10% rating under the corresponding joint DC (e.g., mild limitation of motion at the knee, hip, or shoulder).

20%

Benign bone neoplasm causing moderate symptoms - more consistent pain with use and at rest, moderate limitation of motion in the affected joint or region, occasional need for assistive devices, or moderate functional restriction in occupational or daily activities.

From 38 CFR: Under DC 5015, a 20% rating would be supported when the neoplasm causes functional impairment analogous to, for example, moderate limitation of motion of a major joint (e.g., knee or hip), or moderately painful limitation of a long bone such that occupational and recreational activity is meaningfully restricted.

30%

Benign bone neoplasm causing significant functional impairment - marked limitation of motion, chronic pain substantially restricting daily function, regular use of assistive devices, or significant post-surgical residuals. Condition meaningfully affects the veteran's ability to maintain employment or perform necessary daily activities.

From 38 CFR: DC 5015 analogous ratings at 30% and above reflect severe functional impairment of the affected skeletal area. For example, marked painful limitation of a major lower extremity joint, pathological fracture history, or bony deformity causing significant gait disturbance would support ratings at this level. Ratings above 30% are possible when impairment is equivalent to higher-rated joint/bone analogues.

Pain - Location, Character, and Frequency

How to describe it: Describe exactly where the pain is (e.g., 'along the inner aspect of my right tibia where the neoplasm is located'), what type of pain it is (sharp, aching, throbbing, burning), how severe it is on your worst days (using a 0-10 scale), and how often it occurs. Distinguish between pain at rest, pain with activity, and pain that wakes you at night.

Example: On my worst days, the pain in my left femur where the neoplasm is located is a 9 out of 10. It starts as a deep aching pain that begins within minutes of standing or walking, and even at rest in bed at night it wakes me up 2-3 times. I cannot stand for more than 5 minutes or walk more than half a block without severe pain forcing me to stop.

Examiner listens for: Specificity of pain location, consistency with the documented neoplasm site, pain that limits functional activity, night pain indicating active disease, and pain patterns that match the DeLuca factors of pain on motion, at rest, and with repeated use.

Avoid: Saying 'the pain isn't that bad' or 'I manage it okay' when you are actually relying on pain medication, limiting your activities, or losing sleep. Minimizing pain at the exam can result in a non-compensable or inadequately rated decision.

Functional Limitations - What You Cannot Do

How to describe it: Describe in specific, concrete terms what activities you cannot do or can only do with great difficulty because of the benign bone neoplasm. Use distance, time, weight, and frequency as metrics. Reference both occupational limitations (lifting, standing, walking, sitting) and personal daily activities (dressing, bathing, climbing stairs, driving).

Example: Because of the neoplasm in my right humerus, on my worst days I cannot raise my right arm above shoulder height, cannot carry more than a half-pound without dropping items, cannot button my shirt or tie my shoes without severe pain, and cannot perform my job duties as a warehouse worker. This happens at least 10-15 days per month.

Examiner listens for: Concrete activity limitations tied directly to the neoplasm or its residuals, frequency of bad days versus good days, impact on employment, and whether the veteran compensates by using assistive devices or modifying their behavior.

Avoid: Describing only what you can do on a good day. The VA rates your average and worst-day function - if you tell the examiner 'I can walk okay most days' without mentioning the days you cannot walk at all, your rating may not reflect your true disability level.

Flare-Ups - Frequency, Duration, and Triggers

How to describe it: Explain how often your symptoms worsen significantly (flare-ups), what triggers them (activity, weather, prolonged standing, lifting), how long each flare-up lasts, and what you must do during a flare-up (rest, ice, additional medication, use crutches/wheelchair). Describe the level of disability during a flare-up specifically.

Example: I experience severe flare-ups of pain and swelling at the neoplasm site approximately 3-4 times per month. Each flare-up is triggered by overuse - even moderate activity like grocery shopping - and lasts 2-4 days. During a flare-up I am bedridden for at least one full day, cannot walk without crutches, and require prescription-strength pain medication around the clock.

Examiner listens for: Frequency and predictability of flare-ups, whether flare-ups cause additional functional loss beyond baseline, duration of recovery, and whether flare-ups interfere with employment or daily obligations.

Avoid: Forgetting to mention flare-ups at all, or saying 'I have flare-ups sometimes' without quantifying frequency, duration, or severity. Examiners must document flare-up information under DeLuca - if you don't describe them, they may not be recorded.

Treatment History and Response

How to describe it: Describe all treatments you have received for the benign bone neoplasm in chronological order: surgery (type, date, what was done), radiation therapy, chemotherapy, physical therapy, injections, bracing, and current medications. Explain whether treatments helped, partially helped, or were unsuccessful, and what residuals remain after treatment.

Example: I had surgery in [year] to remove the neoplasm from my right distal femur. After surgery, I had significant improvement but still have chronic pain at the surgical site and my knee range of motion never fully recovered - I can only bend my knee to about 70 degrees now versus 135 degrees before surgery. I wear a hinged knee brace daily and use a cane when walking more than two blocks.

Examiner listens for: Completeness of treatment history, whether treatment was curative or palliative, post-treatment residuals, compliance with recommended treatment, and current treatment needs including assistive devices.

Avoid: Failing to mention all surgeries, therapies, or procedures. The examiner needs a complete picture - omitting prior surgery or radiation can result in an incomplete DBQ and inadequate rating for residuals.

Assistive Device Use

How to describe it: List every assistive device you use and describe how often you use it (daily, several times per week, during flare-ups only), why you need it (pain, instability, weakness, fall prevention), and what activities require its use. Include prescribed devices and devices you purchased yourself.

Example: I use a hinged brace on my right leg every day when I leave the house because without it the pain and instability from my femoral neoplasm makes me feel like my leg will give out. On bad days or flare-ups, I also use a cane or crutches. On my three worst days last month, I used a wheelchair to get around because I could not bear weight at all.

Examiner listens for: Type of device, frequency of use, whether devices are prescribed by a physician, and whether multiple devices are used depending on severity of symptoms on a given day.

Avoid: Not mentioning assistive devices because you feel embarrassed or think they are unimportant. Assistive device use is a direct indicator of functional impairment and is explicitly documented on the DBQ form - it directly affects your rating.

Complications and Residuals

How to describe it: Accurately describe any complications that have arisen from the benign bone neoplasm or its treatment: pathological fractures, bony deformity, nerve compression causing numbness or weakness, joint instability, recurrence of the neoplasm, or adjacent joint arthritis. Be clear about which complications are ongoing versus resolved.

Example: The benign bone neoplasm in my right tibia caused a pathological fracture two years ago that required surgical repair. Since then, I have chronic pain at the fracture site, a visible angulation of my lower leg, and I walk with a permanent limp. The fracture also caused nerve damage that gives me numbness in my right foot and causes me to trip and fall approximately twice per month.

Examiner listens for: Whether complications are present that may warrant separate rating, whether residuals are chronic or episodic, and the direct causal link between the neoplasm and the complications described.

Avoid: Not mentioning complications like pathological fracture history, nerve involvement, or adjacent joint damage because you assume they are already in your records. The examiner needs to hear these from you to ensure they are documented in the DBQ - do not assume they have reviewed everything.